作者: J Stoehlmacher , D J Park , W Zhang , D Yang , S Groshen
关键词: Pathology 、 Pharmacogenetics 、 Genotype 、 GSTP1 、 Oxaliplatin 、 Survival rate 、 Combination chemotherapy 、 Performance status 、 Internal medicine 、 Biology 、 Colorectal cancer 、 Oncology
摘要: … selected from a cohort of patients with metastatic colorectal cancer who were enrolled and treated on a compassionate use protocol of oxaliplatin plus 5-FU (protocol number 3C-98-3) …